#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA2341008	B	Selectivity ratio of IC50 for COX1 in human whole blood to IC50 for COX2 in human whole blood	Homo sapiens	2		tissue-based format	Scientific Literature
2.	ALA2341009	B	Selectivity ratio of IC80 for COX1 in human whole blood to IC80 for COX2 in human whole blood	Homo sapiens	2		tissue-based format	Scientific Literature
3.	ALA2341010	B	Inhibition of COX1 in human whole blood assessed as reduction in TXB2 generation	Homo sapiens	2		single protein format	Scientific Literature
4.	ALA2341011	B	Inhibition of COX2 in human whole blood assessed as reduction in LPS-induced PGE2 generation pre-treated prior to LPS-challenge	Homo sapiens	2		single protein format	Scientific Literature
5.	ALA2341012	F	Inhibition of interleukin 1 beta-induced glycosaminoglycan release in bovine articular cartilage of metacarpophalangeal joints of feet treated 48 hrs after interleukin 1beta-challenge by DMB colorimetric assay	Bos taurus	2		assay format	Scientific Literature
6.	ALA2341013	F	Antiinflammatory activity in Sprague-Dawley/Wistar osteoarthritis model rat assessed as decrease in monoiodoacetate-induced hyperalgesia at 20 mg/kg, po bid for 14 days administered from day of monoiodoacetate-challenge followed by additional compound treatment after 30 mins measured 15 to 21 days post monoiodoacetate challenge by paw pressure test (Rvb = 30.4 +/- 3.1 g)	Rattus norvegicus	2		organism-based format	Scientific Literature
7.	ALA2341014	F	Antiinflammatory activity in Sprague-Dawley/Wistar osteoarthritis model rat assessed as decrease in monoiodoacetate-induced hyperalgesia at 20 mg/kg, po bid for 14 days administered from day of monoiodoacetate-challenge measured 15 to 21 days post monoiodoacetate challenge post by paw pressure test (Rvb = 32.6 +/- 2.9 g)	Rattus norvegicus	2		organism-based format	Scientific Literature
8.	ALA2346431	F	Antiinflammatory activity in Sprague-Dawley/Wistar rat assessed as decrease in carrageenan-induced paw edema at 10 mg/kg, po administered 3 hrs 30 mins after carrageenan-challenge measured after 60 mins (Rvb = 2.48 +/- 0.06 mL)	Rattus norvegicus	2		organism-based format	Scientific Literature
9.	ALA2346433	F	Antiinflammatory activity in Sprague-Dawley/Wistar rat assessed as decrease in carrageenan-induced paw edema at 20 mg/kg, po administered 3 hrs 30 mins after carrageenan-challenge measured after 60 mins (Rvb = 2.48 +/- 0.06 mL)	Rattus norvegicus	10		organism-based format	Scientific Literature
10.	ALA2346437	F	Antiinflammatory activity in Sprague-Dawley/Wistar rat assessed as decrease in carrageenan-induced hyperalgesia at 10 mg/kg, po administered 4 hrs after carrageenan-challenge measured after 120 mins (Rvb = 31.4 +/- 3.7 g)	Rattus norvegicus	2		organism-based format	Scientific Literature
11.	ALA2346438	F	Antiinflammatory activity in Sprague-Dawley/Wistar rat assessed as decrease in carrageenan-induced hyperalgesia at 10 mg/kg, po administered 4 hrs after carrageenan-challenge measured after 60 mins (Rvb = 33.9 +/- 3.7 g)	Rattus norvegicus	2		organism-based format	Scientific Literature
12.	ALA2346439	F	Antiinflammatory activity in Sprague-Dawley/Wistar rat assessed as decrease in carrageenan-induced hyperalgesia at 10 mg/kg, po administered 4 hrs after carrageenan-challenge measured after 30 mins (Rvb = 34.8 +/- 3.0 g)	Rattus norvegicus	2		organism-based format	Scientific Literature
13.	ALA2339166	F	Antiinflammatory activity in Sprague-Dawley/Wistar rat assessed as decrease in carrageenan-induced hyperalgesia at 20 mg/kg, po administered 4 hrs after carrageenan-challenge measured after 120 mins (Rvb = 31.4 +/- 3.7 g)	Rattus norvegicus	10		organism-based format	Scientific Literature
14.	ALA2339167	F	Antiinflammatory activity in Sprague-Dawley/Wistar rat assessed as decrease in carrageenan-induced hyperalgesia at 20 mg/kg, po administered 4 hrs after carrageenan-challenge measured after 60 mins (Rvb = 33.9 +/- 3.7 g)	Rattus norvegicus	10		organism-based format	Scientific Literature
15.	ALA2339168	F	Antiinflammatory activity in Sprague-Dawley/Wistar rat assessed as decrease in carrageenan-induced hyperalgesia at 20 mg/kg, po administered 4 hrs after carrageenan-challenge measured after 30 mins (Rvb = 34.8 +/- 3.0 g)	Rattus norvegicus	10		organism-based format	Scientific Literature
16.	ALA2339169	F	Antinociceptive activity in po dosed Swiss albino mouse assessed as reduction in number of acetic acid-induced writhing counted 5 mins after acetic acid challenge counted for 10 mins	Mus musculus	11		organism-based format	Scientific Literature
17.	ALA2339170	F	Vasorelaxant activity in Wistar rat endothelium-removed thoracic aortic rings assessed as reduction of KCl-induced vasoconstriction at 0.001 uM to 10 uM treated after KCl-challenge in presence of guanylate cyclase inhibitor 1H-[1,2,4]-oxadiazolo[4,3-a]quinoxalin-1-one	Rattus norvegicus	5		tissue-based format	Scientific Literature
18.	ALA2339171	F	Vasorelaxant activity in Wistar rat endothelium-removed thoracic aortic rings assessed as reduction of KCl-induced vasoconstriction treated after KCl-challenge	Rattus norvegicus	6		tissue-based format	Scientific Literature
19.	ALA2339172	F	Vasorelaxant activity in Wistar rat endothelium-removed thoracic aortic rings assessed as reduction of KCl-induced vasoconstriction at 0.001 uM to 10 uM treated after KCl-challenge relative to control	Rattus norvegicus	15		tissue-based format	Scientific Literature
20.	ALA2339173	B	Selectivity index, ratio of IC50 for COX1 in mouse J774 cells to IC50 for COX1 in mouse J774 cells	Mus musculus	14		cell-based format	Scientific Literature